简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-01-20 16:26 Award: Boehringer Ingelheim is Global Top Employer 2022
2022-01-20 15:39 Waters Accelerates Quantitative Mass Spectrometry With New Application on waters_connect Informatics Platform
2022-01-20 10:24 VFMCRP receives EU approval for Tavneos® for the treatment of ANCA-associated vasculitis
2022-01-19 16:48 YouKuai Launched Seven Chef Line Zrou Plant-based RTH Products with Five Chinese Celebrity Chefs, Including Jereme Leung
2022-01-19 10:00 BiologyWorks k(now)™ COVID-19 Clinical Trial Matches 99.1% Accuracy to RT-PCR Tests
2022-01-19 09:57 Aptorum Group Granted The First Patent for its SACT-1 Repurposed Drug For Treatment of Various Cancer Including but Not Limited to Neuroblastoma
2022-01-18 14:49 CSL Behring AG publishes Offer Prospectus on public tender offer for all publicly held shares of Vifor Pharma Ltd.
2022-01-17 20:46 Mary Kay Continues Its Commitment to Skin Science
2022-01-14 18:47 Medisca Signs Deal as Exclusive Global Distributor outside the USA & Israel for the Padagis Line of ORA Products
2022-01-14 18:20 Headspace Health Announces Acquisition of AI-Driven Mental Health and Wellness Company, Sayana
2022-01-14 16:37 Takeda to Acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta (γδ) T Cell Engager Therapies Targeting Solid Tumors
2022-01-14 16:07 Liverpool CCG and Community Pharmacy Liverpool Launch FebriDx® Service at More Than 100 Community Pharmacies
2022-01-13 19:04 SPIE, the International Society for Optics and Photonics, Announces Its 2022 Society Awards
2022-01-12 18:51 Perceval: CORCYM Announces the First Patient Implanted in China
2022-01-12 18:47 Takeda Emphasizes Strategy for Delivering Sustainable Growth Over Next Decade at the 40th Annual J.P. Morgan Healthcare Conference
2022-01-11 18:17 QUANTA Dialysis Technologies Appoints Meghan Fitzgerald and Leslie Norwalk to Board of Directors
2022-01-11 09:58 Aptorum Group Announces Updates on the Clinical Validation of its RPIDD Infectious Disease Liquid Biopsy Technology
2022-01-11 09:55 Aptorum Group Announces the Launch of its Oncology and Autoimmune Discovery and Development Platform Targeting Unmet Mutations and Novel Biomarkers
2022-01-11 09:45 Aptorum Group Announces Completion of Phase I Clinical Trials for ALS-4 and SACT-1, Small Molecule Drugs Targeted for Infections Caused by Staphylococcus Aureus and Neuroblastoma
2022-01-11 09:31 Iksuda Therapeutics Deepens Clinical Pipeline Through Licensing Agreement for Her2 Antibody Drug Conjugate Programme From LegoChem Biosciences

Business Wire Weibo

Press Releases

Latest Releases